Moderna (MRNA) Completes Submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine

Go back to Moderna (MRNA) Completes Submission of BLA to U.S. Food and Drug Administration for its COVID-19 Vaccine

Moderna, Inc’s (MRNA) Vaccine’s FDA Approval Could Lead to Greater Market Share in Coming Years - Analyst

August 25, 2021 1:09 PM EDT

Earlier today, Moderna, Inc. (Nasdaq: MRNA) announced it has completed the rolling submission process for its Biologics... More